University of Patras
Ανάπτυξη υπερευαίσθητης ποσοτικής μεθόδου προσδιορισμού του mRNA του νέου γονιδίου SRA1 και κλινική αξιολόγηση του στον καρκίνο του μαστού και της ωοθήκης
Abstract
dc:descriptionUnder physiological conditions every cell goes through stages of growth, proliferation and death, which are controlled by specific mechanisms. Moreover, cell proliferation depends on a number of restrictive mechanisms, such as the presence of growth factors, the ability to grow on a monolayer and the necessity of adhesion to surfaces. Mutation in the genes that control these restrictive factors, can convert a normal cell to its cancerous counterpart. Cancer, monoclonal in origin, constitutes a group of diseases which are related with changes in the cellular behaviour, and is characterized by the formation of malignant tumours. Additionally, it is the result of a multistage process with multifactorial justification. As far as the classification of tumours is concerned, they are characterized in accordance with their cell of origin. Consequently, carcinoma denotes a type of cancer that emanates from epithelial cells, while sarcoma is derived from muscular cells or from cells of connective or adipose tissue. Cancers of the haematopoietic cells constitute the various types of leukaemia. In order to describe the tumours, they are classified according to their degree of differentiation. This is done in such a way that they are distinguished as tumours of high, medium or poor differentiation or as undifferentiated or anaplastic tumours. Finally, the classification of tumours includes the grade and the stage of the disease. The staging of the disease usually follows the TNM system, which includes the evaluation of three parameters: the size of the tumour, the presence or absence of metastatic lymph nodes and of distant metastases. Cancer development is mainly owed to environmental factors. However, in terms of the higher predisposition of certain groups of people for specific forms of cancer, it is also characterized as a genetic disease, mainly in an inter-familial scale. The natural history of the disease can be separated into four stages: 1) the induction phase that lasts 15-30 years, the period in which the individual is periodically exposed to certain cancer-causing factors, 2) the in situ phase, lasting from 5 up to 10 years, during which pre-cancerous lesions, that affect the tissues, are observed, 3) the invasion phase, stage that can last from 1 to 5 years in which the cancer cells enter deeper into adjacent tissues, reaching the veins and the lymphatic vessels and 4) the phase of dissemination where metastases in other tissues are observed. Breast cancer constitutes the most widespread form of malignancy in women with the incidence of the disease increasing in the developed western countries. The worldwide mortality rates of breast cancer oscillate between 5.5 and 22.6 per 100,000 individuals. However, the better sensitization of the population, the development of methodologies that can diagnose the disease during its early stages and the profound understanding of the molecular mechanisms of the disease have reduced the mortality rates of breast cancer. The majority of breast cancer cases constitute lesions of the epithelial cells of the lobules and of the ducts. Depending on the cell of origin and the degree of invasion, breast cancer is classified as ductal in situ carcinoma, lobular in situ carcinoma, invasive ductal carcinoma or invasive lobular carcinoma. The invasive ductal and lobular carcinomas can disseminate into other parts of the body via the lymphatic system or the blood circulation. Except of the afore mentioned types of breast cancer, there are also a number of mainly invasive forms, which appear less frequently
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Leotsakou, Theoni
- Λεουτσάκου, Θεώνη
Subjects
dc:subject × 18Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18203